Table 3.
Genes a | Forward primer (5′-3′) | Reverse primer (5′-3′) | Length | Accession No. |
---|---|---|---|---|
TLR2 | GCAGCCGCTTCAAAACTCAT | GAACAAAGCCCTCAAAGCGG | 105 | NP_997977 |
MyD88 | GTTGCGCTAAACATGAGCGT | GTCTTCTCTGTCCAGCTCCG | 237 | A8QMS7 |
FADD | GGCAGAAGATAACACGGCCT | ATTTGCGGCCTAGTTTTCGC | 200 | NP_001373289 |
NF-κB | TCACAGGGTCCTCGATGTCT | CTGGCTGTTTGGAGACAGGT | 78 | NP_001001839 |
TGF-β | CGTCTTCCAGCAAGCTCAGA | TCCGAAGACGCAATTCTGCT | 116 | NP_878293 |
IL-10 | CACAACCCCAATCGACTCCA | GAGCAAATCAAGCTCCCCCA | 175 | NP_001018621 |
IL-8 | GGAAGACCTGCCTCAATCCC | GGGGCGGAGGTAGAATTTGG | 118 | XP_001342606 |
TNF-α | GCAATCCGCTCAATCTGCAC | GCAGCGCCGAGGTAAATAGT | 74 | NP_998024 |
Caspase8 | ACCAGGACCTGCTGTCATTG | TATCTGGAGATGCGCTGCTG | 160 | XP_685430 |
Bcl-2 | GCGCTTCAACGCAGTCATAG | GCAGCTAGACCAAAGACCGT | 291 | XP_001341214 |
Bcl-xl | CAAGGAGGATGGGAACGCTT | TTCTGTGCAATGAGTCCCCC | 146 | NP_571882 |
AP-1 | CGTGAGTGTCACCTCGACTC | GTCCTCATAAACCGGCGACT | 127 | NP_956281 |
Nrf2 | CTGCCGTAAACGCAAGATGG | ATCCGTTGACTGCTGAAGGG | 287 | NM_182889.1 |
Keap1 | GGAAGTCACCCTTCGAGACG | AGAGGACGTGAAGAACGCAG | 107 | NM_182864.2 |
CAT | GGAAGAGGATGACGAAGAG | GTTACGGCGAGATGATGT | 232 | NP_570987 |
SOD | ACAGAAGAGAAGTATCAGGAG | CACCGTAACAGCAGACAT | 228 | NP_956270 |
Hsp70 | TCCATCACAAGGGCACGTTT | CAGGGCTTTCTCAACTGGGT | 78 | Q91233.1 |
β-actin | ACCCCATTGAGCACGGTATT | GCTCCTCAGGGGCAACTCTC | 96 | KJ126772.1 |
aTLR2, Toll like receptor 2; MyD88, myeloid differentiation factor 8; FADD, Fas-associating protein with a novel death domain; NF-κB, Nuclear factor Kappa B; TGF-β, Transforming growth factor-β; IL-10, Interleukin 10; IL-8, Interleukin 8; TNF-α, Tumor necrosis factor-α; Caspase8, Cysteine-requiring aspartate protease 8; Bcl-2, B-cell lymphoma-2; Bcl-xl, B-cell lymphoma-xl; AP-1, Activating protein-1; Nrf2, Nuclear factor erythroid 2-related factor 2; Keap1, Kelch-like ECH-associated protein1; CAT, Catalase; SOD, Superoxide dismutase; Hsp70, Heat shock protein 70.